Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
Y
2926
DELISTED
Alleghany Corp
Y
| $606K | ﹤0.01% |
987
-37,363
| -97% | -$22.5M |
|
2927
Oil-Dri
ODC
$1.43B
| $603K | ﹤0.01% |
30,006
+5,350
| +22% | +$103K |
|
|
AMRN
2928
CALL
Amarin Corp
AMRN
$297M
| $602K | ﹤0.01% |
+10,000
| New | +$742K |
|
2929
Preformed Line Products
PLPC
$1.39B
| $601K | ﹤0.01% |
9,230
-22,002
| -70% | -$1.55M |
|
2930
Strategic Education
STRA
$1.98B
| $601K | ﹤0.01% |
5,949
-6,540
| -52% | -$619K |
|
2931
LeMaitre Vascular
LMAT
$2.37B
| $600K | ﹤0.01% |
+16,571
| New | +$574K |
|
2932
Invesco Dorsey Wright Energy Momentum ETF
PXI
$58.5M
| $599K | ﹤0.01% |
15,773
-5,674
| -26% | -$220K |
|
|
CFMS
2933
DELISTED
Conformis, Inc. Common Stock
CFMS
| $598K | ﹤0.01% |
16,493
-8,363
| -34% | -$351K |
|
2934
Pacific Biosciences
PACB
$435M
| $594K | ﹤0.01% |
289,523
+163,767
| +130% | +$425K |
|
2935
Vanguard Consumer Discretionary ETF
VCR
$5.97B
| $592K | ﹤0.01% |
3,733
+2,259
| +153% | +$369K |
|
2936
Cinemark Holdings
CNK
$4.07B
| $588K | ﹤0.01% |
15,614
-8,886
| -36% | -$337K |
|
2937
Guggenheim Strategic Opportunities Fund
GOF
$2.2B
| $588K | ﹤0.01% |
28,961
+8,257
| +40% | +$170K |
|
|
CHSP
2938
DELISTED
Chesapeake Lodging Trust
CHSP
| $584K | ﹤0.01% |
20,985
-72,592
| -78% | -$1.95M |
|
2939
CALL
Celldex Therapeutics
CLDX
$2.94B
| $583K | ﹤0.01% |
+16,667
| New | +$646K |
|
|
KBAL
2940
DELISTED
Kimball International
KBAL
| $583K | ﹤0.01% |
34,195
-23,221
| -40% | -$411K |
|
2941
Federal Agricultural Mortgage
AGM
$2.32B
| $582K | ﹤0.01% |
6,686
-2,296
| -26% | -$186K |
|
2942
iShares Russell Mid-Cap Growth ETF
IWP
$19.4B
| $580K | ﹤0.01% |
+9,442
| New | +$590K |
|
2943
DHI Group
DHX
$177M
| $576K | ﹤0.01% |
359,829
-193,051
| -35% | -$342K |
|
2944
OR Royalties Inc
OR
$5.53B
| $576K | ﹤0.01% |
+59,606
| New | +$629K |
|
2945
Adtran
ADTN
$675M
| $575K | ﹤0.01% |
36,997
-387,556
| -91% | -$6.47M |
|
2946
Nuveen Quality Municipal Income Fund
NAD
$2.73B
| $571K | ﹤0.01% |
43,481
+31,181
| +254% | +$416K |
|
2947
Gladstone Capital
GLAD
$427M
| $568K | ﹤0.01% |
+33,046
| New | +$594K |
|
|
NXTM
2948
DELISTED
NxStage Medical Inc.
NXTM
| $567K | ﹤0.01% |
22,814
-14,155
| -38% | -$344K |
|
|
SRG
2949
Seritage Growth Properties
SRG
$138M
| $564K | ﹤0.01% |
15,864
-300,711
| -95% | -$11.7M |
|
2950
Cornerstone Strategic Value Fund
CLM
$2.16B
| $563K | ﹤0.01% |
+37,458
| New | +$576K |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.